Question Title

* 1. To receive continuing education credits please enter information requested. Nurses may earn at least 6.25 hours of CE credits. Your certificate will be sent to your email address within five business days. Please take a few moments to answer all the questions in the survey. IN ORDER TO RECEIVE CREDIT BE CERTAIN TO CLICK ON "DONE" AFTER THE FINAL QUESTION. Mark you calendar for the next AAIFNC symposium, Saturday, 29 April 2023.

Question Title

* 2. The University of Buffalo School of Medicine & Biomedical Sciences has designated the "Allergy, Asthma & Immunologic Disorders: Bridges to Understanding" as an ACCME-approved activity.  Please indicate below the number of credits you are claiming.

Question Title

* 3. Please record, on a scale of 1-5 your degree of agreement with each of the following statements.

  1. Do Not Agree 2. Mildly Disagree 3. Neither Agree nor Disagree 4. Agree 5. Strongly Agree
This program increased my knowledge of recent developments in patient-centered healthcare.
The program provided adequate time for questions.
As a result of the program I am able to recognize advantages & limitations of JAK inhibitors.
As a result of the program I am able to recognize common residual symptoms following COVID-19 infection.
As a result of the program I am able to understand safety of food allergy treatments.
As a result of the program I am able to describe mechanisms thought to underlie chronic cough.
The right amount of information was presented.
Overall, the program met my expectations.
There was sufficient time allotted for the presentations.
The program was free of commercial bias.

Question Title

* 4. Please rate, on a scale of 1-5 with 5 being the highest, your opinion of each speaker's knowledge of the subject matter presented.

  1 2 3 4 5
Seema Aceves, MD
Mark Boguniewicz, MD
Larry Borish, MD
Lekshmi Santhosh, MD
Jacky Smith, MB, ChB, FRCP, PhD
Julie Wang, MD
Gil Yosipovitch, MD

Question Title

* 5. Please rate, on a scale of 1-5 with 5 being the highest, the ability of each speaker to communicate effectively.

  1 2 3 4 5
Seema Aceves, MD
Mark Boguniewicz, MD
Larry Borish, MD
Lekshmi Santhosh, MD
Jacky Smith, MB, ChB, FRCP, PhD
Julie Wang, MD
Gil Yosipovitch, MD

Question Title

* 6. Which of the following course features attracted you to this program?

Question Title

* 7. If you are able how will you change your practice as a result of attending this activity?

Question Title

* 8. Please answer 'yes' or 'no' to the barriers that might prevent you from applying the knowledge gained from this meeting to your practice. Other, please specify (i.e. cost to implement, regulatory concerns etc.) in "Comments" box

  Yes No
Lack of time
Lack of experience
Lack of opportunity (patients)
Lack of resources (equipment, staff)
Reimbursement/insurance issues
Administrative barriers
No barriers

Question Title

* 9. With respect to today's symposium topics and future meeting topics please tell us about your interests and educational needs.

  Enthusiastically Want More Wouldn't Mind More No strong opinion Wouldn't Mind Less Vehemently Want Less
Autoinflammatory diseases
Immunodeficiency
Anaphylaxis
Immunotherapy/Biologics
Microbiome & relationship to human disease
Allergic conjunctivitis
Eczema
Allergic rhinitis
Hives
Asthma
Food allergy
Hereditary angioedema
Eosinophilia
Mast Cell Disorders
Drug Allergies
Climate Change & Allergic Disorders
Chronic Cough
Cancer Immunology

Question Title

* 10. Please tell us about your impression of the program as an overall environment for a useful and comfortable educational experience

  Agree No strong opinion Disagree
Registration was simple & accurate.
Lecture room temperature was optimal.
Sound level & quality were optimal.
Seating was comfortable & adequate.
Audiovisual presentation was optimal.
Subjects were interesting and relevant.
Moderators were prepared & fair.
Adequate time was provided to visit sponsors.
Breaks were optimal in length.
Product theaters were useful and well-presented
Refreshments were excellent.
Breakfast was excellent.
Lunch was excellent.
COVID-19 Safety concerns were adequately addressed

T